AzTrials
AzTrials

Accelerate Tooth MovementNCT06975358

Accelerated Orthodontics With Alveolar Decortication Plus CGF Injection

A study testing Alveolar decortication plus CGF injection and canine retraction without acceleration in people with Accelerate Tooth Movement, run by Safa Basiouny Alawy at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the present study is to evaluate alveolar bone decortication combined with CGF Injection on tooth movement acceleration Read more about this study

Who is it for?
Ages 16 to 22 years
Conditions the study is for
Accelerate Tooth Movement
What is being tested?
Alveolar decortication plus CGF injection and canine retraction without acceleration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
20 May 2025to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 22 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Age of the patients ranged from 16: 22 years old.
  • Malocclusion that requires extraction of the maxillary first premolar and canine retraction (e.g. class I bimaxillary dentoalveolar protrusion and class II div 1 malocclusion).
  • Maximum anchorage needed for the maxillary arch as a part of the orthodontic treatment plan.
  • Good oral hygiene and periodontal condition.

Who cannot join

  • Medically compromised patients.
  • Severe crowding in the maxillary arch.
  • Chronic intake of NSAIDs or any medication that interfere with OTM.
  • Previous orthodontic treatment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site, 1 recruiting
  • Tanta University

    Tanta, Tanta, 6624033

    Safa B Alawy, PhD, +201009088252, safa_basyouny@dent.tanta.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Impact of Alveolar Decortication Combined With CGF Injection on Acceleration of Maxillary Canine Retraction-A Randomized Clinical Trial

The aim of the present study is to evaluate alveolar bone decortication combined with CGF Injection on tooth movement acceleration

Being tested
Alveolar decortication plus CGF injection, canine retraction without acceleration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alveolar decortication plus CGF injectionProcedure or surgery

    Experimental sides will receive CGF injection (70 units) disto-buccal and disto-palatal to the maxillary canine after performing decortication. After administration of local anesthesia, two-line flap will be performed from the mesial surface of the maxillary second premolar to the distal surface of the maxillary canine Mucoperiosteal flap will be reflected in the buccal side. Two millimeters of marginal crestal bone will be held intact and using a high-speed drill and a round carbide bur (1mm diameter) under copious saline irrigation, the cortical wall will be penetrated to reach marrow spaces. Multiple perforations (10 holes for standardization) in the cortical bone will be created. The surgical site will then rinsed, and the flap will be repositioned and sutured.

  • canine retraction without accelerationProcedure or surgery

    in the control side, the maxillary canine will be retracted without any acceleration procedure

Study groups in NCT06975358
Study groupRoleWhat they receive
Alveolar decortication plus CGFExperimentalAlveolar decortication followed by submucosal CGF injection (70 units) disto-buccal and disto-palatal to the maxillary canine will be randomly assigned to one side of the maxillary arch (experimental) while the other side serve as (control) receiving orthodontic treatment without any additional intervention
Receives: Procedure: Alveolar decortication plus CGF injection
ControlActive comparatorthe other side of the maxillary arch will receive the usual orthodontic treatment without any additional intervention
Receives: Procedure: canine retraction without acceleration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. rate of canine retraction

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2025
  2. Study start20 May 2025
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06975358
Sponsor's protocol ID
#R-OS-12-24-3158
Status last verified
Sep 2026
First submitted
8 May 2025
Last updated
29 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Alveolar decortication plus CGF injection and canine retraction without acceleration in people with Accelerate Tooth Movement, run by Safa Basiouny Alawy at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Safa B Alawy, PhD (0201009088252, safa_basyouny@dent.tanta.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

rate of canine retraction (time frame: 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in